MD482Z - Method for prevention of pelvic organs radiotherapy complications - Google Patents

Method for prevention of pelvic organs radiotherapy complications

Info

Publication number
MD482Z
MD482Z MDS20110120A MDS20110120A MD482Z MD 482 Z MD482 Z MD 482Z MD S20110120 A MDS20110120 A MD S20110120A MD S20110120 A MDS20110120 A MD S20110120A MD 482 Z MD482 Z MD 482Z
Authority
MD
Moldova
Prior art keywords
radiotherapy
capsule
complications
prevention
course
Prior art date
Application number
MDS20110120A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Виктор ГИКАВЫЙ
Вадим ГАВРИЛУЦА
Виталие ГИКАВЫЙ
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MDS20110120A priority Critical patent/MD482Z/en
Publication of MD482Y publication Critical patent/MD482Y/en
Publication of MD482Z publication Critical patent/MD482Z/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to medicine, namely to the radiotherapy treatment in oncology.The invention consists in the fact that it is administered once a day immediately after meals, within 15 days from the start of the course of radiotherapy, intravenously 5 ml of 5% solution of ascorbic acid and perorally one capsule (33000 UA) of retinol, one capsule (0.2 g) of tocopherol and one tablet (0.2 g) of methyluracil. At the same time, it is simultaneously administered pumpkin seed oil rectally in the form of microclysters, in a volume of 20 ml an hour before the start of the radiotherapy session. The oil is also taken perorally, one teaspoon (5 ml) twice a day, 2…3 days before the start of the course of radiotherapy and then along its whole length.The result is a decrease in local and general postradiational complications in oncologic patients.
MDS20110120A 2011-06-29 2011-06-29 Method for prevention of pelvic organs radiotherapy complications MD482Z (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20110120A MD482Z (en) 2011-06-29 2011-06-29 Method for prevention of pelvic organs radiotherapy complications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20110120A MD482Z (en) 2011-06-29 2011-06-29 Method for prevention of pelvic organs radiotherapy complications

Publications (2)

Publication Number Publication Date
MD482Y MD482Y (en) 2012-02-29
MD482Z true MD482Z (en) 2012-09-30

Family

ID=45815380

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20110120A MD482Z (en) 2011-06-29 2011-06-29 Method for prevention of pelvic organs radiotherapy complications

Country Status (1)

Country Link
MD (1) MD482Z (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2197977C2 (en) * 2001-04-17 2003-02-10 Дмитриенко Николай Васильевич Pumpkin seed oil eliciting anti-inflammatory, antiulcerous and hepatoprotective effect and method of its preparing
EA201001000A1 (en) * 2010-04-19 2011-10-31 Алмагуль Тулеуовна Маншарипова ANTIOXIDANT MEANS OIL BALSAM "JEWELAX"
  • 2011

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2197977C2 (en) * 2001-04-17 2003-02-10 Дмитриенко Николай Васильевич Pumpkin seed oil eliciting anti-inflammatory, antiulcerous and hepatoprotective effect and method of its preparing
EA201001000A1 (en) * 2010-04-19 2011-10-31 Алмагуль Тулеуовна Маншарипова ANTIOXIDANT MEANS OIL BALSAM "JEWELAX"

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Каприн А.Д., Семин А.В., Костин А.А. Эффективность препарата "Канефрон Н" у онкологически больных получающих лучевую терапию на органы малого таза. Человек и лекарство, №5, том 15, 2007 *
Ролик И.С. Биологические препараты в реабилитации больных раком: руководство для врачей. Москва, Арнебия, 2000 *
Справочник Видаль. Лекарственные препараты в России, издание 15-е, 2009 *

Also Published As

Publication number Publication date
MD482Y (en) 2012-02-29

Similar Documents

Publication Publication Date Title
EA201591371A1 (en) Pyridine derivatives as easily degraded inhibitors ROCK
MX2019001286A (en) Cannabis composition.
JO3784B1 (en) Combined use of anti pd-1 and anti m-csf antibodies in the treatment of cancer
EP3808367A3 (en) Targeting aneurysm disease by modulating phagocytosis pathways
IN2014CN02703A (en)
MX2019005623A (en) Dose and regimen for hdm2-p53 interaction inhibitors.
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
MX2018000546A (en) Pharmaceutical composition containing celecoxib and tramadol.
MX2017003561A (en) Compositions and methods for cannabinoid coatings for use in drug delivery.
EA201491427A1 (en) SUBSTITUTED PHENYLIMIDAZOPIRAZOLES AND THEIR APPLICATION
MX2022015629A (en) Use of vibegron to treat overactive bladder.
MX2022011372A (en) Zinc-î³-pga compositions and methods for treating cancer.
MX2023000187A (en) Dosing of vibegron for treatment of overactive bladder.
JOP20210201A1 (en) Blood glucose lowering compound
NZ720273A (en) Preparations and methods for treating a gd2 positive cancer
MD482Y (en) Method for prevention of pelvic organs radiotherapy complications
MX2019007360A (en) Azabicyclo-substituted triazole derivative, preparation method thereof, and application of same in medicine.
MX2020001217A (en) Methods of treating symptoms of gastroparesis using velusetrag.
MD493Z (en) Method for prophylaxis of postradiation complications in oncological diseases
MD501Z (en) Method for prophylaxis of postradiation complications in oncologic diseases
RU2017140779A (en) COMPOSITIONS FOR CANCER TREATMENT
MX2018003289A (en) COMPOSITIONS AND METHODS OF USE OF ß-HYDROXY-ß-METHYLBUTYRATE (HMB) FOR ENHANCING RECOVERY FROM SOFT TISSUE TRAUMA.
UA105586U (en) Method for treating hepatic encephalopathy
UA95037U (en) METHOD OF TREATMENT OF NON-ALCOHOLIC STEATOGEPATITIS
MD854Z (en) Method for treating locally advanced II-III stage cervical canrcinoma

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)